Literature DB >> 32729927

An acidic residue buried in the dimer interface of isocitrate dehydrogenase 1 (IDH1) helps regulate catalysis and pH sensitivity.

Lucas A Luna1, Zachary Lesecq1, Katharine A White2, An Hoang1, David A Scott3, Olga Zagnitko3, Andrey A Bobkov3, Diane L Barber4, Jamie M Schiffer5, Daniel G Isom6, Christal D Sohl1.   

Abstract

Isocitrate dehydrogenase 1 (IDH1) catalyzes the reversible NADP+-dependent conversion of isocitrate to α-ketoglutarate (αKG) to provide critical cytosolic substrates and drive NADPH-dependent reactions like lipid biosynthesis and glutathione regeneration. In biochemical studies, the forward reaction is studied at neutral pH, while the reverse reaction is typically characterized in more acidic buffers. This led us to question whether IDH1 catalysis is pH-regulated, which would have functional implications under conditions that alter cellular pH, like apoptosis, hypoxia, cancer, and neurodegenerative diseases. Here, we show evidence of catalytic regulation of IDH1 by pH, identifying a trend of increasing kcat values for αKG production upon increasing pH in the buffers we tested. To understand the molecular determinants of IDH1 pH sensitivity, we used the pHinder algorithm to identify buried ionizable residues predicted to have shifted pKa values. Such residues can serve as pH sensors, with changes in protonation states leading to conformational changes that regulate catalysis. We identified an acidic residue buried at the IDH1 dimer interface, D273, with a predicted pKa value upshifted into the physiological range. D273 point mutations had decreased catalytic efficiency and, importantly, loss of pH-regulated catalysis. Based on these findings, we conclude that IDH1 activity is regulated, at least in part, by pH. We show this regulation is mediated by at least one buried acidic residue ∼12 Å from the IDH1 active site. By establishing mechanisms of regulation of this well-conserved enzyme, we highlight catalytic features that may be susceptible to pH changes caused by cell stress and disease.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  buried ionizable residues; cancer; enzyme kinetics; pH regulation; post-translational modification; tumor metabolism

Mesh:

Substances:

Year:  2020        PMID: 32729927      PMCID: PMC7996970          DOI: 10.1042/BCJ20200311

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  114 in total

Review 1.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

3.  Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.

Authors:  Katharine A White; Diego Garrido Ruiz; Zachary A Szpiech; Nicolas B Strauli; Ryan D Hernandez; Matthew P Jacobson; Diane L Barber
Journal:  Sci Signal       Date:  2017-09-05       Impact factor: 8.192

4.  Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery.

Authors:  Alan Merk; Alberto Bartesaghi; Soojay Banerjee; Veronica Falconieri; Prashant Rao; Mindy I Davis; Rajan Pragani; Matthew B Boxer; Lesley A Earl; Jacqueline L S Milne; Sriram Subramaniam
Journal:  Cell       Date:  2016-05-26       Impact factor: 41.582

Review 5.  Newer aspects of glutamine/glutamate metabolism: the role of acute pH changes.

Authors:  I Nissim
Journal:  Am J Physiol       Date:  1999-10

6.  Hypoxia-induced intracellular acidification in isolated sheep heart Purkinje fibres and the effects of temperature.

Authors:  C M Bright; D Ellis
Journal:  J Mol Cell Cardiol       Date:  1994-04       Impact factor: 5.000

7.  Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants.

Authors:  Diego Avellaneda Matteo; Grace A Wells; Lucas A Luna; Adam J Grunseth; Olga Zagnitko; David A Scott; An Hoang; Amit Luthra; Manal A Swairjo; Jamie M Schiffer; Christal D Sohl
Journal:  Biochem J       Date:  2018-10-22       Impact factor: 3.857

8.  Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

Authors:  Courtney D DiNardo; Eytan M Stein; Stéphane de Botton; Gail J Roboz; Jessica K Altman; Alice S Mims; Ronan Swords; Robert H Collins; Gabriel N Mannis; Daniel A Pollyea; Will Donnellan; Amir T Fathi; Arnaud Pigneux; Harry P Erba; Gabrielle T Prince; Anthony S Stein; Geoffrey L Uy; James M Foran; Elie Traer; Robert K Stuart; Martha L Arellano; James L Slack; Mikkael A Sekeres; Christophe Willekens; Sung Choe; Hongfang Wang; Vickie Zhang; Katharine E Yen; Stephanie M Kapsalis; Hua Yang; David Dai; Bin Fan; Meredith Goldwasser; Hua Liu; Sam Agresta; Bin Wu; Eyal C Attar; Martin S Tallman; Richard M Stone; Hagop M Kantarjian
Journal:  N Engl J Med       Date:  2018-06-02       Impact factor: 91.245

9.  Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.

Authors:  Darrell R Borger; Kenneth K Tanabe; Kenneth C Fan; Hector U Lopez; Valeria R Fantin; Kimberly S Straley; David P Schenkein; Aram F Hezel; Marek Ancukiewicz; Hannah M Liebman; Eunice L Kwak; Jeffrey W Clark; David P Ryan; Vikram Deshpande; Dora Dias-Santagata; Leif W Ellisen; Andrew X Zhu; A John Iafrate
Journal:  Oncologist       Date:  2011-12-16       Impact factor: 5.837

10.  Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1.

Authors:  Sheryl P Denker; Diane L Barber
Journal:  J Cell Biol       Date:  2002-12-16       Impact factor: 10.539

View more
  3 in total

Review 1.  Regulation of energy metabolism in human pluripotent stem cells.

Authors:  Weiwei Liu; Guokai Chen
Journal:  Cell Mol Life Sci       Date:  2021-11-13       Impact factor: 9.261

Review 2.  Isocitrate dehydrogenase gene variants in cancer and their clinical significance.

Authors:  Thomas Cadoux-Hudson; Christopher J Schofield; James S O McCullagh
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

Review 3.  Probing altered enzyme activity in the biochemical characterization of cancer.

Authors:  Mowaffaq Adam Ahmed Adam; Christal D Sohl
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.